GLYCOMED INCORPORATED has a total of 11 patent applications. Its first patent ever was published in 1989. It filed its patents most often in Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CENTAURI THERAPEUTICS LTD, FARMHISPANIA and KUNMING PHARMACEUTICAL GROUP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 11 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Macromolecular chemistry and polymers | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Polysaccharides | |
#5 | Sugars | |
#6 | Heterocyclic compounds | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Levy Daniel E | 3 |
#2 | Holme Kevin R | 3 |
#3 | Tang Peng Cho | 3 |
#4 | Musser John H | 3 |
#5 | Galardy Richard E | 3 |
#6 | Grobelny Damian | 2 |
#7 | Nematalla Assad | 2 |
#8 | Schultz Gregory S | 2 |
#9 | Shaklee Patrick N | 1 |
#10 | Macher Bruce | 1 |
Publication | Filing date | Title |
---|---|---|
AU3433293A | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors | |
AU1902592A | Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |